Ultrashort regimen of lansoprazole-amoxicillin-azithromycin for eradicating Helicobacter pylori

American Journal of Health-System Pharmacy

Volumn 58, Issue 19, 2001, Pages 1819-1823

  Chahine, Corinne ^a   Moukhachen, Oussayma ^a   Chedid, Marwan ^b   Araj, George F ^b   Sharara, Ala I ^b  

^a LEBANESE AMERICAN UNIVERSITY   (Lebanon)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Amoxicillin trihydrate; Azithromycin; Combined therapy; Dosage schedules; Gastrointestinal drugs; Helicobacter infections; Lansoprazole; Macrolides; Penicillins

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; LANSOPRAZOLE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ERADICATION THERAPY; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0035478974     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/58.19.1819     Document Type: Article

References (41)

1. Labenz J, Borsch G. Evidence for the essential role of Helicobacter pylori in gastric ulcer disease. Gut. 1994; 35:19-22.
2. Forbes GM, Glaser ME, Cullen DJ et al. Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up. Lancet. 1994; 343:258-60.
3. Bodger K, Daly MJ, Heatley RV. Clinical economics review: Helicobacter pylori-associated peptic ulcer disease. Aliment Pharmacol Ther. 1997; 11:273-82.
4. Hosking SW, Ling TK, Yung MY et al. Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer. BMJ. 1992; 305:502-4.
5. Tytgat GN. Peptic ulcer and Helicobacter pylori: eradication and relapse. Scand J Gastroenterol Suppl. 1995; 210:70-2.
6. Solcia E, Villani L, Fiocca R et al. Effects of eradication of Helicobacter pylori on gastritis in duodenal ulcer patients. Scand J Gastroenterol Suppl. 1994; 201:28-34.
7. Parsonnet J, Friedman GD, Vandersteen DP et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991; 325:1127-31.
8. Parsonnet J, Hansen S, Rodriguez L et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med. 1994; 330: 1267-71.
9. Bechi P, Balzi M, Becciolini A et al. Helicobacter pylori and cell proliferation of the gastric mucosa: possible implications for gastric carcinogenesis. Am J Gastroenterol. 1996; 91:271-6.
10. Graham DY, Lew GM, Klein PD et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med. 1992; 116:705-8.
11. Bayerdorffer E, Miehlke S, Mannes GA et al. Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers. Gastroenterology. 1995; 108:1412-7.
12. Graham KS, Malaty H, el-Zimaity HM et al. Variability with omeprazole-amoxicillin combinations for treatment of Helicobacter pylori infection. Am J Gastroenterol. 1995; 90:1415-8.
13. Riemann JF, Schilling D, Schauwecker P et al. Cure with omeprazole plus amoxicillin versus long-term ranitidine therapy in Helicobacter pylori-associated peptic ulcer bleeding. Gastrointest Endosc. 1997; 46:299-304.
14. Harford W, Lanza F, Arora A et al. Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection. Helicobacter. 1996; 1:243-50.
15. Lamouliatte H, Cayla R, Zerbib F et al. Dual therapy using a double dose of lansoprazole with amoxicillin versus triple therapy using a double dose of lansoprazole, amoxicillin, and clarithromycin to eradicate Helicobacter pylori infection: results of a prospective randomized open study. Am J Gastroenterol 1998; 93:1531-4.
16. Miehlke S, Meining A, Lehn N et al. Comparison of omeprazole, metronidazole and clarithromycin with omeprazole/ amoxicillin dual-therapy for the cure of Helicobacter pylori infection. Digestion. 1998; 59:646-50.
17. Bazzoli F, Zagari M, Pozzato P et al. Evaluation of short-term low-dose triple therapy for the eradication of Helicobacter pylori by factorial design in a randomized, double-blind, controlled study. Aliment Pharmacol Ther. 1998; 12:439-45.
18. Vcev A, Stimac D, Ivandic A et al. Pantoprazole, amoxycillin and either azithromycin or clarithromycin for eradication of Helicobacter pylori in duodenal ulcer. Aliment Pharmacol Ther. 2000; 14:69-72.
19. Van Zwet AA, de Boer WA, Schneeberger PM et al. Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in the Netherlands. Eur J Clin Microbiol Infect Dis. 1996; 15:861-4.
20. Blandizzi C, Malizia T, Gherardi G et al. Gastric mucosal distribution and clinical efficacy of azithromycin in patients with Helicobacter pylori related gastritis. J Antimicrob Chemother. 1998; 42:75-82.
21. Krichhoff RM, Laufen H, Schacke G et al. Determination of azithromycin in gastric biopsy samples. Int J Clin Pharmacol Ther. 1999; 37:361-4.
22. Marchi M, Vacondio R, Bagnulo A et al. [Azithromycin-omeprazole. Treatment for the eradication of Helicobacter pylori.] Minerva Gastroenterol Dietol. 1994; 40: 47-9. In Italian.
23. Bertoni G, Sassatelli R, Nigrisoli E et al. Triple therapy with azithromycin, omeprazole, and amoxicillin is highly effective in the eradication of Helicobacter pylori: a controlled trial versus omeprazole plus amoxicillin. Am J Gastroenterol. 1996; 91:258-63.
24. Di Mario F, Dal Bo N, Grassi SA et al. Azithromycin for the cure of Helicobacter pylori infection. Am J Gastroenterol. 1996; 91:264-7.
25. Cammarota G, Tursi A, Papa A et al. Helicobacter pylori eradication using one-week low-dose lansoprazole plus amoxycillin and either clarithromycin or azithromycin. Aliment Pharmacol Ther. 1996; 10:997-1000.
26. Caselli M, Trevisani L, Tursi A et al. Short-term low-dose triple therapy with azithromycin, metronidazole and lansoprazole appears highly effective for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1997; 9:45-8.
27. Vcev A, Vceva A, Ivandic A et al. [Omeprazole and azithromycin with and without metronidazole in the eradication of Helicobacter pylori in duodenal ulcer disease.] Lijec Vjesn. 1997; 119: 210-3. In Serbo-Croatian.
28. Vcev A, Vceva A, Takac B et al. Omeprazole, azithromycin and amoxicillin or amoxicillin plus clavulanic acid in eradication of Helicobacter pylori in duodenal ulcer disease. Acta Med Croatica. 1998; 52:209-14.
29. Trevisani L, Sartori S, Caselli M et al. A four-day low dose triple therapy regimen for the treatment of Helicobacter pylori infection. Am J Gastroenterol 1998; 93: 390-3.
30. Trevisani L, Sartori S, Galvani F et al. Evaluation of a new ultrashort triple therapy for Helicobacter pylori disease. Aliment Pharmacol Ther. 1998; 12:1269-72.
31. Vcev A, Stimac D, Vceva A et al. High dose omeprazole plus amoxicillin and azithromycin in eradication of Helicobacter pylori in duodenal ulcers. Helicobacter. 1999; 4:54-7.
32. Cammarota G, Papa A, Cianci R et al. Three-day antibiotic therapy with azithromycin and tinidazole plus lansoprazole or pantoprazole to cure Helicobacter pylori infection: a pilot study. Eur J Gastroenterol Hepatol. 1999; 11:247-50.
33. Flores S, Opazo H, Valderrama D et al. [Triple therapy of short-term with azithromycin, amoxycillin and omeprazole for the eradication of Helicobacter pylori.] Rev Med Chil. 2000; 128:509-12. In Spanish.
34. Calabrese C, Di Febo G, Areni A et al. Pantoprazole, azithromycin and tinidazole: short duration triple therapy for eradication of Helicobacter pylori infection. Aliment Pharmacol Ther. 2000; 14: 1613-7.
35. Megraud F, Lehn N, Lind T et al. Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study. Antimicrob Agents Chemother. 1999; 43:2747-52.
36. Al-Assi MT, Genta RM, Karttunen TJ et al. Azithromycin triple therapy for Helicobacter pylori infection: azithromycin, tetracycline, and bismuth. Am J Gastroenterol. 1995; 90:403-5.
37. Chey WD, Fisher L, Barnett J et al. Low-versus high-dose azithromycin triple therapy for Helicobacter pylori infection. Aliment Pharmacol Ther. 1998; 12:1263-7.
38. Malizia T, Tejada M, Marchetti F et al. Synergic interactions of macrolides and proton-pump inhibitors against Helicobacter pylori: a comparative in-vitro study. J Antimicrob Chemother. 1998; 41 (suppl B):29-35.
39. Laine L, Estrada R, Trujillo M et al. Randomized comparison of differing periods of twice-a-day triple therapy for the eradication of Helicobacter pylori. Aliment Pharmacol Ther. 1996; 10:1029-33.
40. Calvet X, Garcia N, Lopez T et al. A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection. Aliment Pharmacol Ther. 2000; 14:603-9.
41. Kalenic S, Plecko V, Kresic S et al. Helicobacter pylori: in vitro induction of resistance to azithromycin. Chemotherapy. 1998; 44:17-20.